M
myTomorrows
Biotech & Life Sciences · Amsterdam, Netherlands · Founded 2012
Earlier access to innovative drugs worldwide MoreLess
myTomorrows operates in the healthcare sector, focusing on bridging the gap between patients with serious diseases and BioPharma companies developing new treatments. The company serves patients, healthcare professionals, and BioPharma companies by providing a platform that facilitates patient recruitment for clinical trials, expanded access management, and Real World data collection. myTomorrows generates revenue through partnerships with BioPharma companies, offering them services that streamline the process of patient recruitment and data collection. The business model is centered on creating a connected hub that supports both patients in need of new treatment options and BioPharma companies looking to bring their innovations to market more efficiently. The market it operates in includes the global healthcare and pharmaceutical industries, with a particular focus on innovative treatments and clinical trials.
Keywords: patient access, BioPharma, clinical trials, expanded access, Real World data, healthcare platform, patient recruitment, treatment options, serious diseases, healthcare professionals.
Company overview
myTomorrows company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2012
- Headquarters
- Amsterdam, Netherlands
- Employees
- 139
- Open positions
- 21
- Dealroom signal
- 86.4
Valuation & funding
myTomorrows funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Nov 2025 | $29M | $116M | Avego | ↗ |
| SERIES AOther financing | Jan 2017 | $11M | $44M | Octopus Ventures · EQT Ventures · Balderton Capital · Sofinnova Partners | ↗ |
| SEEDOther financing | Oct 2014 | $5M | $20M | Balderton Capital · Sofinnova Partners | — |
| EARLY VCOther financing | Feb 2014 | $2.2M | $8.8M | Undisclosed | — |
| EARLY VCOther financing | Jan 2012 | $3.8M | $15M | Undisclosed | — |
Growth signals
myTomorrows website traffic
Latest recorded traffic for myTomorrows is 15K monthly website visits, down 37.5% over the last three months. myTomorrows's team grew 9.4% over the past year.
Hiring
Open positions at myTomorrows
Current openings linked to this company in Dealroom.
Comparisons
myTomorrows compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
myTomorrows's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where myTomorrows has talent and traffic
team presence
In the news
Latest news about myTomorrows
Recent press, funding announcements, and product moves mentioning myTomorrows — open to read from the original sources.
Market sentiment
What the market is saying about myTomorrows
An AI-synthesized read of the highest-engagement posts about myTomorrows on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See myTomorrows’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.